This site is intended for healthcare professionals

ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

EPIVIR-HBV
Viral infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

EPIVIR-HBV Rx

Generic Name and Formulations:
Lamivudine 100mg; tabs.

Company:
GlaxoSmithKline

Therapeutic Use:

Indications for EPIVIR-HBV:

Chronic hepatitis B associated with viral replication and active liver inflammation.

Adult:

100mg once daily. Renal impairment: CrCl 30–49mL/min: 100mg for 1st dose then 50mg once daily; CrCl 15–29mL/min: 100mg for 1st dose then 25mg once daily; CrCl 5–14mL/min: 35mg for 1st dose then 15mg once daily; CrCl <5mL/min: 35mg for 1st dose then 10mg once daily.

Children:

<2yrs: not recommended. 2–17yrs: 3mg/kg (max 100mg) once daily. Renal impairment: consider dose reduction.

Contraindications:

Concomitant zalcitabine.

Warnings/Precautions:

Unrecognized or untreated HIV infection (do HIV testing and counseling before and periodically during treatment). Not for treatment of HIV and HBV co-infections (use doses appropriate for HIV). Suspend if lactic acidosis or hepatotoxicity (eg, hepatomegaly and steatosis) occurs. Risk factors for liver disease. Women, obesity, or prolonged nucleoside exposure: increased risk of toxicity. Post-treatment exacerbation of hepatitis B; monitor closely during and for several months after treatment. Emergence of resistance-associated HBV substitutions: monitor ALT and HBV DNA levels during treatment. Diabetes (oral soln). Reevaluate annually. Pregnancy. Nursing mothers.

Interactions:

See Contraindications. Caution with drugs eliminated by active organic cationic secretion (eg, trimethoprim). Increased lamivudine absorption with TMP/SMX; increased zidovudine levels with lamivudine (clinical significance unknown).

See Also:

EPIVIR-HBV ORAL SOLUTION

Pharmacological Class:

Nucleoside analogue (reverse transcriptase inhibitor).

Adverse Reactions:

Ear, nose, and throat infections, sore throat, diarrhea; rare: lactic acidosis, severe hepatomegaly with steatosis, emergence of viral mutations.

Note:

Register pregnant patients exposed to lamivudine by calling (800) 258-4263.

Generic Availability:

Tabs (YES); Soln (NO)

How Supplied:

Tabs—60; Soln—240mL

Join MIMS Learning now to manage all your CPD and notes in one place!

By registering you agree with our Terms and Conditions and Privacy Policy.


Already a MIMS Learning member?

Sign In Now »
Red flag CPD modules
0.50 Credits
Red flags

Groin swelling - red flag symptomsExternal web site

This red flags article explains signs and symptoms of potentially serious pathology in patients presenting...

0.50 Credits
Red flags

Erectile dysfunction - red flag symptomsExternal web site

This article by Dr Tillmann Jacobi covers the possible red flag symptoms to consider when a patient...

0.50 Credits
Red flags

Headache - red flag symptomsExternal web site

Dr Suneeta Kochhar provides an overview of red flag symptoms in patients presenting with headaches...

Font Awesome Icons
View more
Clinical review CPD modules
1.50 Credits
Clinical Review

Basal cell carcinoma: clinical reviewExternal web site

In this article, Dr David Brass and Dr Neil Rajan discuss the risk factors for BCC, making the diagnosis...

1.50 Credits
Clinical Review

Cardiomyopathy: clinical reviewExternal web site

This article by Dr Rajiv Sankaranarayanan covers the diagnosis and management of cardiomyopathy. Key...

1.50 Credits
Clinical Review

Parkinson's disease: clinical reviewExternal web site

Dr Benjamin Simpson provides an in-depth overview of Parkinson’s disease, including information on risk...

Font Awesome Icons
View more

is free, fast, and customized just for you!

Already a member?

Sign In Now »